Ulcerative Colitis Basics

The more you know about ulcerative colitis (UC), the easier it is to play an active role in your treatment. In this section of the Web site, you’ll learn about what UC is, its symptoms, how it’s diagnosed, and treatment options.

Inflammation plays a big role in ulcerative colitis. Learn more about the “I” in IBD.

Why are mesalamine formulations, including Lialda^® (mesalamine), the “first-line” treatments for ulcerative colitis? Learn more about UC treatment options.

How bad are your ulcerative colitis symptoms? See how doctors define severity.

Watch this video

to see how UC affects the colon and how Lialda is designed to work.

The Inside Story on UC

Lialda is approved for the induction of remission in patients with active, mild to moderate ulcerative colitis. The safety and effectiveness of Lialda have been established in 2 eight-week clinical trials.

Important Safety Information

You should not take Lialda if you are allergic to salicylates (including mesalamine or aspirin) or to any of the ingredients of Lialda. Tell your doctor if you have a stomach blockage or are allergic to sulfasalazine. Mesalamine has been associated with a syndrome that may be difficult to distinguish from an ulcerative colitis flare-up. If you experience cramping, abdominal pain, bloody diarrhea, fever, headache or rash, talk to your doctor immediately. Some patients taking mesalamine have reported heart-related hypersensitivity reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart. Tell your doctor if you have problems with your liver or kidneys.

In worldwide clinical trials, Lialda was generally well tolerated. The most common adverse events were headache and flatulence. As with other medications, some serious side effects may occur. Less than 1% of patients experienced inflammation of the pancreas, which led to discontinuation of therapy with Lialda.

Please see Lialda Full Prescribing Information

Site Map | Contact Us | Privacy Policy | Unsubscribe | Shire US Inc.

©2010 LIA-01364 02/10
Lialda^® is a registered trademark of Shire LLC. MMX^® is a registered trademark owned by Cosmo Technologies Ltd, Ireland, a wholly owned subsidiary of Cosmo Pharmaceuticals SpA.
© 2010 Shire US Inc., Wayne, PA 19087 (800) 828-2088. All rights reserved.

This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.